A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy Volunteers

Clinical trial NCT05184517 · COMPLETED

Trial details

NCT number: NCT05184517
Sponsor: OphRx Ltd.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2023-01-23
Primary completion: 2023-07-06
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.